Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of β-Lactam Agents Against a Challenge Set of Gram-Negative Pathogens-Reference-Cited by-同舟云学术

Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of β-Lactam Agents Against a Challenge Set of Gram-Negative Pathogens

Published:2020-04-01 Issue:4 Volume:26 Page:319-328
ISSN:1076-6294
Container-title:Microbial Drug Resistance
language:en
Short-container-title:Microbial Drug Resistance

Author:

Mendes Rodrigo E.¹,Rhomberg Paul R.¹,Lister Troy²,Cotroneo Nicole²,Rubio Aileen²,Flamm Robert K.¹

Affiliation:

1. JMI Laboratories, North Liberty, Iowa.

2. Spero Therapeutics Inc., Cambridge, Massachusetts.

Publisher

Mary Ann Liebert Inc

Subject

Microbiology (medical),Pharmacology,Immunology,Microbiology

Link

https://www.liebertpub.com/doi/pdf/10.1089/mdr.2019.0198

Reference40 articles.

1. Estimating the burden of antimicrobial resistance: a systematic literature review

2. Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets

3. The global epidemiology of carbapenemase-producing Enterobacteriaceae

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combatting resistance: Understanding multi-drug resistant pathogens in intensive care units;Biomedicine & Pharmacotherapy;2023-11

2. Identification of a small molecule 0390 as a potent antimicrobial agent to combat antibiotic-resistant Escherichia coli;Frontiers in Microbiology;2022-12-15

3. Minocycline and the SPR741 Adjuvant Are an Efficacious Antibacterial Combination for Acinetobacter baumannii Infections;Antibiotics;2022-09-15

4. Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens;Frontiers in Cellular and Infection Microbiology;2022-05-20

5. SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant Klebsiella pneumoniae, Its Biofilms, and Persister Cells;Frontiers in Cellular and Infection Microbiology;2022-03-18